Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Fosfomycin
2. Fosfomycin Trometamol Salt
3. Fosfomycin Tromethamine
4. Phosphomycin
5. Phosphonomycin
6. Tromethamine, Fosfomycin
1. 78964-85-9 (tromethamine)
2. [1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azanium;hydroxy-[(2r,3s)-3-methyloxiran-2-yl]phosphinate
3. Tromethamine-fosfomycin
4. Fosfotricin
5. Monurol Sachet
6. Fosfomycin Compd. With Trometamol
7. Einecs 279-018-8
8. Fosfomycin Tromethaminel
9. Unii-7fxw6u30gy
10. Akos015896108
11. Ac-4209
12. Ks-1266
13. (2r-cis)-(3-methyloxiranyl)phosphonic Acid, Compound With 2-amino-2-(hydroxymethyl)propane-1,3-diol (1:1)
| Molecular Weight | 259.19 g/mol |
|---|---|
| Molecular Formula | C7H18NO7P |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 259.08208891 g/mol |
| Monoisotopic Mass | 259.08208891 g/mol |
| Topological Polar Surface Area | 161 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 190 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Taste Masking
Thickeners and Stabilizers
Coating Systems & Additives
Parenteral
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
14
PharmaCompass offers a list of Fosfomycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fosfomycin manufacturer or Fosfomycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fosfomycin manufacturer or Fosfomycin supplier.
PharmaCompass also assists you with knowing the Fosfomycin API Price utilized in the formulation of products. Fosfomycin API Price is not always fixed or binding as the Fosfomycin Price is obtained through a variety of data sources. The Fosfomycin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A MONUROL manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MONUROL, including repackagers and relabelers. The FDA regulates MONUROL manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MONUROL API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of MONUROL manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A MONUROL supplier is an individual or a company that provides MONUROL active pharmaceutical ingredient (API) or MONUROL finished formulations upon request. The MONUROL suppliers may include MONUROL API manufacturers, exporters, distributors and traders.
click here to find a list of MONUROL suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A MONUROL DMF (Drug Master File) is a document detailing the whole manufacturing process of MONUROL active pharmaceutical ingredient (API) in detail. Different forms of MONUROL DMFs exist exist since differing nations have different regulations, such as MONUROL USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A MONUROL DMF submitted to regulatory agencies in the US is known as a USDMF. MONUROL USDMF includes data on MONUROL's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The MONUROL USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of MONUROL suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The MONUROL Drug Master File in Japan (MONUROL JDMF) empowers MONUROL API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the MONUROL JDMF during the approval evaluation for pharmaceutical products. At the time of MONUROL JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of MONUROL suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a MONUROL Drug Master File in Korea (MONUROL KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of MONUROL. The MFDS reviews the MONUROL KDMF as part of the drug registration process and uses the information provided in the MONUROL KDMF to evaluate the safety and efficacy of the drug.
After submitting a MONUROL KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their MONUROL API can apply through the Korea Drug Master File (KDMF).
click here to find a list of MONUROL suppliers with KDMF on PharmaCompass.
A MONUROL CEP of the European Pharmacopoeia monograph is often referred to as a MONUROL Certificate of Suitability (COS). The purpose of a MONUROL CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of MONUROL EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of MONUROL to their clients by showing that a MONUROL CEP has been issued for it. The manufacturer submits a MONUROL CEP (COS) as part of the market authorization procedure, and it takes on the role of a MONUROL CEP holder for the record. Additionally, the data presented in the MONUROL CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the MONUROL DMF.
A MONUROL CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. MONUROL CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of MONUROL suppliers with CEP (COS) on PharmaCompass.
A MONUROL written confirmation (MONUROL WC) is an official document issued by a regulatory agency to a MONUROL manufacturer, verifying that the manufacturing facility of a MONUROL active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting MONUROL APIs or MONUROL finished pharmaceutical products to another nation, regulatory agencies frequently require a MONUROL WC (written confirmation) as part of the regulatory process.
click here to find a list of MONUROL suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MONUROL as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for MONUROL API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture MONUROL as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain MONUROL and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MONUROL NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of MONUROL suppliers with NDC on PharmaCompass.
MONUROL Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of MONUROL GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right MONUROL GMP manufacturer or MONUROL GMP API supplier for your needs.
A MONUROL CoA (Certificate of Analysis) is a formal document that attests to MONUROL's compliance with MONUROL specifications and serves as a tool for batch-level quality control.
MONUROL CoA mostly includes findings from lab analyses of a specific batch. For each MONUROL CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
MONUROL may be tested according to a variety of international standards, such as European Pharmacopoeia (MONUROL EP), MONUROL JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MONUROL USP).
